Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Molecular Bacterial Pathogenesis

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1525789

This article is part of the Research Topic Mechanisms of microbial persistence and strategies to counter them View all articles

Screening the receptors for Mycoplasma penetrans P35 lipoprotein and characterization of its functional binding domainsScreen of the receptors of Mycoplasma penetrans P35 lipoprotein and identification of the corresponding binding functional domains

Provisionally accepted
Xia Li Xia Li 1Xiaoliu Wang Xiaoliu Wang 2Youyuan Ye Youyuan Ye 1Zhuo Zeng Zhuo Zeng 1Li Chen Li Chen 1Kailan Peng Kailan Peng 1Hua Xiao Hua Xiao 1Siqi Gao Siqi Gao 1Haodang Luo Haodang Luo 1Yanhua Zeng Yanhua Zeng 2,3*
  • 1 Hengyang Medical College, University of South China, Hengyang, Hunan Province, China
  • 2 The First Affiliated Hospital, University of South China, Hengyang, Hunan Province, China
  • 3 University of South China, Hengyang, China

The final, formatted version of the article will be published soon.

    Mycoplasma penetrans, a prokaryotic microorganism initially isolated from the urine of a patient infected with human immunodeficiency virus (HIV), possesses a distinctive elongated flask-like shape and a tip-like structure. This unique morphology has been shown to facilitate its ability to invade cells both in vitro and in vivo. The adhesion of M. penetrans to host cells relies on lipid-associated membrane proteins (LAMPs), especially P35 lipoprotein, which is exposed on the mycoplasmal surface. In this study, modified Virus Overlay Protein Binding Assay (VOPBA) was employed to identify P35-interacting proteins from membrane protein extracts of SV40-immortalized human uroepithelial (SV-HUC-1) cells. Through recombinant protein binding assays, siRNA-mediated knockdown, ELISA, Far-Western blot, and inhibition experiments, the binding mechanisms and functional domains were further elucidated. Results demonstrated that the P35 lipoprotein interacts with γ-actin (ACTG1). Recombinant P35 specifically bound to both recombinant and endogenous ACTG1 on the host cell membrane. ACTG1 partially inhibited the adhesion of P35 and M. penetrans to host cells. In SV-HUC-1 cells transfected with ACTG1-siRNA, adhesion of P35 and M. penetrans was significantly reduced. Further studies identified the functional domains responsible for binding between P35 and ACTG1 at amino acid residues 35-42 and 179-186. These findings suggest that ACTG1 on the host cell membrane may act as a receptor for the P35 lipoprotein, facilitating the adhesion of M. penetrans to host cells. The identified critical binding regions of P35 represent potential targets for therapeutic interventions against M. penetrans infections.

    Keywords: Mycoplasma penetrans, P35 lipoprotein, ACTG1, receptor, Binding functional domains

    Received: 10 Nov 2024; Accepted: 24 Feb 2025.

    Copyright: © 2025 Li, Wang, Ye, Zeng, Chen, Peng, Xiao, Gao, Luo and Zeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yanhua Zeng, University of South China, Hengyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more